Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Crossed back above $32. Now lets get to $33 on the march back to $34.50
OOPS after doing some more reading turns out its a delisting letter due to drop below $1.00
The work STAFF threw me of?? I was wondering why they care about staff #???? Things you learn doing this
Cheers
What is a deficiency letter ???
news story out?
BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter
REUTERS 1:16 PM ET 4/16/2018
* APRICUS BIOSCIENCES SAYS ON APRIL 10, CO RECEIVED A NASDAQ STAFF DEFICIENCY LETTER - SEC FILING Source : https://bit.ly/2JMowAJ Further company coverage: (Reuters.Briefs@thomsonreuters.com)
Thanks for the post
For those that know
? is it possible for them to submit information to answer the deficiencies noted during the original meeting and come away with a approval???
I know reaching for some good news.
Time to buy news story out today?
JC Penney (NYSE: JCP)
Trading at just $3.00 per share, JC Penney is the riskiest stock of the group. However, with the risk comes potential high reward.
The company saw modest improvement in the 2017 holiday season and has grown its e-commerce initiative by double figures.
Adding appliances to take up the slack from a near-dead Sears and offering home services have worked to improve the bottom line.
With the stock down by nearly 50% in the last 52 weeks, bottom fishers rejoice. A small base has formed at $3.00 per share and buying now makes sense with a target price of $6.00 per share.
Sold
Got out finally with a profit
To big a bounce to let ride.
This will settle lower soon and I will watch for possible buy back in ??
Has a long way to go before approval
Ridicules spreads Bid and ask
B 21.44 Ask 21.99
Morning news
GTx (NASDAQ:GTXI) price target raised to $45 (168% upside) at Stifel citing bullish prospects for enobosarm.
Wow Q&A longer than presentation Sad company
Agree. All it was was a heads up.
Yes I also looked for other announcements and did not find. It still shows them not meeting listing requirements this am. If I rememer correctly, once the $1 limit broken it has to go back above and stay above or clock to de list starts. I personally figured this would happen when they missed aproval. Starts new cycle to RS stock IMO
I use Fidelity Active trader pro. When you put in stock symbol to get quote a red bar comes up with message
Cheers
Failed to meet NASDAQ continued listing requirments message popped up today
Maybe some good earning news will find its way out and run this stock to $7 ??
Thanks. Shows P2 results due by END 2018, to me means will see in 2019. Then we have P# to finance and wait for P3 ??
Thats a long way in future to justify the rise in price we have been seeing Since Nov 17?? Dont get me wrong but seeing the rise we have seen I expected some news that was coming sooner?
Cheers
Thanks for the thought
Its so far in future for aproval though??
Cant find any info on when study/testing will be submited?
Guess I need to go and read transcript of presentation
Cheers
Profitable again
Never thought I would see a break even after RS 12/5/16
Up a couple cents today
Were do you see value?
Sold foreign rights
Sold rights for USA
Future earnings wont cover salaries???
What am I missing?
Unless they resubmit FAST its toast
Poor managment
Big question is WHY?
What is driving?
Happy its going up but cant find any news as to why??
Wed ?
Anyone care to guess what trigered a .75 cent pop today?
From MFool article
3 Reasons to Be Hopeful of a J.C. Penney Stock Turnaround
The company has had some mild good news recently.
Daniel B. Kline (TMFDankline) Feb 4, 2018 at 9:02AM
J.C. Penney (NYSE:JCP) has not had an easy few years. The chain's woes date back to 2011 when it hired former Apple (NASDAQ: AAPL) retail executive Ron Johnson as its CEO.
In his disastrous 17-month tenure, Johnson got rid of much of what the company's loyal customers liked about the brand. The CEO knew that the retail marketplace was changing, but he misjudged how to react to those changes and only lasted 17 months before being replaced by his predecessor, Myron Ullman.
After righting the ship, or at least slowing down its sinking, Ullman gave way to Marvin Ellison, who has slowly rebuilt the brand. It's not smooth sailing ahead for J.C. Penney, but there are reasons to believe the company has a chance at reversing its fortunes.
The exterior of a J.C. Penney
J.C. PENNEY HAS SHOWN SIGNS THAT IT'S TURNING AROUND. IMAGE SOURCE: J.C. PENNEY.
The holidays were strong
After a disappointing 2016 holiday season sapped some of its turnaround momentum, J.C. Penney delivered in 2017. The company saw a same-store sales increase of 3.4%.
"We are very encouraged with our overall comp sales performance during the holiday season, which was led by home, beauty and fine jewelry. Additionally, our apparel categories continue to demonstrate improved comp performance, particularly in women's and kids," said Ellison, in a press release. Ellison noted that e-commerce comps grew by double digits as well.
Yes I follow the company. Its been a looser for so long I still do not understand how stopping results in stock price going up. No near term results due so why stock goes from $7.50 to $15.50 ????????
Normaly dont see this kind of good movement unless good news coming SOON???? Cheers
Were are you finding info that it was stoped? and why? Thanks
Article out today
Stocks to Sell: Synergy Pharmaceuticals (SGYP)
Stocks to Sell: Synergy Pharmaceuticals (SGYP)
Source: Shutterstock
All-Time Low: $1.53 (opening price on OTCBB), November 19, 2008
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) first started trading on the pink sheets back in 2008 at $1.53-per-share. The stock would clear $20 within two years — and since then, SGYP has been nothing but trouble.
Short-sellers are circling the stock: over 30% of the float now is sold short. Oppenheimer downgraded SGYP earlier this month, citing the likely need for another dilutive share offering to raise cash. Five days later, Chris Lau on this site detailed the many challenges facing SGYP.
To be fair, Lau argued SGYP might be due for a bounce. Its main drug, Truvance, is used to treat CIC (chronic idiopathic constipation) and it is seeing sharp growth in prescriptions. Synergy continues to burn cash — the key reason Oppenheimer is worried about further dilution — but could stabilize that burn and turn the corner if Truvance gains traction. And with the stock still roughly 50% above its initial price, it would take a roughly one-third decline to reach a new low.
That low still seems possible, if not outright likely, in 2018. Short-sellers in the pharmaceutical space tend to be attuned to prescription growth and market movements, and they clearly see little risk in betting against SGYP even after a long decline. The cash burn is going to drive another offering at some point, even if it doesn’t come as quick as Oppenheimer forecasts, and that offering likely will drive SGYP lower.
It increasingly looks like SGYP’s only way out is to sell itself to a larger company with a larger, better sales force. But acquirers hardly are motivated to buy Synergy at the moment, with bankruptcy risk reasonably significant. To avoid breaking $2 and hitting all-time lows, Synergy needs a turnaround. But there just isn’t enough to see that turnaround coming any time soon.
What kind news tomorrow????????? Cheers
Seems it woke up .
8 to 16 cents lots volume/
wonder whats up??????
Looks like it woke up for xmas
Go look at 5 yr chart
This dud is not going up any time soon
It matters big time
To brake even your price must go up 10 times what it is
No chance
This is third RS in 3 years
Price needs to go to $300 to break even
This is gamble not investing
Dont forget 1 for 25 3/7/16
1 for 10 9/2/15
Above were announcement dates.
I thought it might drop to 2.40 with shorts pushing dow? Seems 2.90 area will hold? If so to me good news as shorts cant push down because news is getting better. Yesterday financial TV news said all retail stores doing better??? Yes all depends on sales but cost of sale will be something to look at???? I do think JCP will be around in future. To much getting better but slowley??
Trading ?
Looking at the drop are we going to retest low of 11/13 or hold?
Thought it was looking like possible drop to 11/7 low of 2.35?
Stock has been on down word slide all of Dec??
I was thinking it would hold around 3.50
None of the drop makes sense to me???
Seems this stoped trading 11/ 17/17 ? Any one know what is going on?
I cant find any news any were old or new?
Held most day of the and closed higher. Good sign?
Reminder
Third Quarter Fiscal 2017 Financial Results Conference Call
The Company will release its third quarter 2017 financial results on Friday, Nov. 10, at 7:30 a.m. ET. The news release will be followed by a live conference call and webcast conducted by Chairman and Chief Executive Officer Marvin R. Ellison and Chief Financial Officer Jeff Davis that will begin at 8:30 a.m. ET.
To access the conference call, please dial (844) 243-9275, or (225) 283-0394 for international callers, and reference 3996839 conference ID or visit the Company's investor relations website at http://ir.jcpenney.com. Supplemental slides will be available on the Company's investor relations website approximately 10 minutes before the start of the conference call.
J.C. Penney (JCP) downgraded by Citi from Neutral to Sell
If it is fake news then I would expect Pennies to put out some kind of statment?????
Only slightly positive news ??
"Third quarter same-store sales are expected to increase in the range of 0.6 percent to 0.8 percent. The retailer expects to report an adjusted third quarter loss in the range of 40 to 45 cents a share."
OOPS forgot to take the light of DIM
Light is shinning bright at end of tunnel
agree 100%
Seems no one thinking?
All flash mob mentality
Then throw in big $$$ forcing short and have loss
It would be nice to see JCP anounce some good earnings NOV 10 and short LOOSE BIG maybe then can get back to orderly market??